Dr. R. Venkatragavan is an accomplished research and development leader with over two decades of experience in synthetic organic and medicinal chemistry, specializing in API process development, scale-up, and regulatory documentation. He currently serves as the Technical Director at Erythro Pharma Pvt. Ltd., where he oversees end-to-end development and commercialization of complex active pharmaceutical ingredients, ensuring seamless compliance with global regulatory standards including US-FDA and EMA.

​

Prior to his current role, Dr. Venkatragavan led R&D and technical operations at Nuray Chemicals Pvt. Ltd., managing the complete lifecycle of API projects—from literature survey and route design to tech transfer, process validation, and DMF support. His contributions have been pivotal in the successful development and regulatory approval of numerous APIs such as Treprostinil Sodium, Trientine Dihydrochloride, Tafamidis Meglumine, Cinacalcet Hydrochloride, and Teriflunomide.

​

Earlier, he held key scientific positions at Eurofins Advinus, Aragen Life Sciences, and Syngene International, where he spearheaded medicinal chemistry programs on oncology and kinase inhibitors, developed novel synthetic methodologies, and managed cross-functional research teams delivering projects from milligram to kilogram scales.

Dr. Venkatragavan earned his Ph.D. in Synthetic Organic and Medicinal Chemistry from Vellore Institute of Technology, following his M.Phil. and M.Sc. in Chemistry from the University of Madras. His doctoral research led to multiple publications in reputed journals including European Journal of Medicinal Chemistry and Tetrahedron Letters.

A strategic thinker and hands-on leader, Dr. Venkatragavan brings deep expertise in process optimization, non-infringing synthesis, regulatory documentation, and technical leadership—bridging innovation and compliance in the global pharmaceutical landscape.